Vacca A, Ribatti D, Iurlaro M, Albini A, Minischetti M, Bussolino F, Pellegrino A, Ria R, Rusnati M, Presta M, Vincenti V, Persico M G, Dammacco F
Department of Biomedical Sciences and Human Oncology, Policlinico, Bari, Italy.
Int J Clin Lab Res. 1998;28(1):55-68. doi: 10.1007/s005990050018.
Human lymphoproliferative diseases can be hypothesized to invade locally and to metastatize via mechanisms similar to those developed by a variety of solid tumors, i.e., the secretion of extracellular matrix-degrading enzymes and stimulation of angiogenesis. To assess this hypothesis, Namalwa, Raji, and Daudi cell lines (Burkitt's lymphoma), LIK and SB cell lines (B-cell lymphoblastic leukemia), CEM and Jurkat cell lines (T-cell lymphoblastic leukemia), and U266 cell line (multiple myeloma) were evaluated for their capacity to produce matrix metalloproteinase-2 and -9, and urokinase-type plasminogen activator. These cell lines were also assessed for their ability: (1) to produce the angiogenic basic fibroblast growth factor and vascular endothelial growth factor; (2) to induce an angiogenic phenotype in cultured endothelial cells, represented by cell proliferation, chemotaxis, and morphogenesis; (3) to stimulate angiogenesis in different in vivo experimental models. All cell lines expressed the mRNA for one or both metalloproteinases. Namalwa, Raji, LIK, SB, and U266 cells secreted the active form of both metalloproteinases, while Daudi, CEM, and Jurkat cells produced metalloproteinase-2 but not-9. In contrast, urokinase-type plasminogen activator was secreted only by SB cells. While Raji, LIK, SB, CEM, and Jurkat cells secreted both basic fibroblast growth factor and vascular endothelial growth factor, Daudi and U266 cells produced only the former, and Namalwa cells only the latter. Accordingly, the conditioned medium of all cell lines stimulated cell proliferation and/or chemotaxis in cultured endothelial cells, with the exception of that of Namalwa cells which was ineffective. The conditioned medium of CEM and Jurkat cells induced morphogenesis in cultured endothelial cells grown on a reconstituted basement membrane (Matrigel). Lastly, Namalwa, Raji, LIK, SB, U266, CEM, and Jurkat cells induced angiogenesis and mononuclear cell recruitment in the murine Matrigel sponge model and in a chick embryo chorioallantoic membrane assay. The extent of angiogenesis in both models was strictly correlated with the density of the mononuclear cell infiltrate. The results indicate that human lymphoproliferative disease cells possess both local and remote invasive ability via the secretion of matrix-degrading enzymes and the induction of angiogenesis which is fostered by host inflammatory cells and by an intervening ensemble of angiogenic factors.
可以假设人类淋巴增殖性疾病会通过与多种实体瘤相似的机制进行局部侵袭和转移,即分泌细胞外基质降解酶并刺激血管生成。为了验证这一假设,对Namalwa、Raji和Daudi细胞系(伯基特淋巴瘤)、LIK和SB细胞系(B细胞淋巴细胞白血病)、CEM和Jurkat细胞系(T细胞淋巴细胞白血病)以及U266细胞系(多发性骨髓瘤)产生基质金属蛋白酶-2和-9以及尿激酶型纤溶酶原激活物的能力进行了评估。还评估了这些细胞系的以下能力:(1)产生促血管生成的碱性成纤维细胞生长因子和血管内皮生长因子;(2)在培养的内皮细胞中诱导促血管生成表型,表现为细胞增殖、趋化性和形态发生;(3)在不同的体内实验模型中刺激血管生成。所有细胞系均表达一种或两种金属蛋白酶的mRNA。Namalwa、Raji、LIK、SB和U266细胞分泌两种金属蛋白酶的活性形式,而Daudi、CEM和Jurkat细胞产生金属蛋白酶-2但不产生-9。相比之下,尿激酶型纤溶酶原激活物仅由SB细胞分泌。虽然Raji、LIK、SB、CEM和Jurkat细胞分泌碱性成纤维细胞生长因子和血管内皮生长因子,但Daudi和U266细胞仅产生前者,Namalwa细胞仅产生后者。因此,除了无效的Namalwa细胞条件培养基外,所有细胞系的条件培养基均能刺激培养的内皮细胞增殖和/或趋化性。CEM和Jurkat细胞的条件培养基能在重构基底膜(基质胶)上生长的培养内皮细胞中诱导形态发生。最后,Namalwa、Raji、LIK、SB、U266、CEM和Jurkat细胞在小鼠基质胶海绵模型和鸡胚绒毛尿囊膜试验中诱导血管生成和单核细胞募集。两种模型中的血管生成程度与单核细胞浸润密度密切相关。结果表明,人类淋巴增殖性疾病细胞通过分泌基质降解酶以及诱导血管生成而具有局部和远处侵袭能力,血管生成由宿主炎症细胞和一系列中间的血管生成因子促进。